Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Pieter P. E. van Lierop"'
Autor:
Mattienne R. van der Kamp, Monique Tabak, Sophia E. J. A. de Rooij, Pieter P. E. van Lierop, Boony J. Thio
Publikováno v:
Frontiers in Pediatrics, Vol 8 (2020)
The COVID-19 crisis has pressured hospital-based care for children with high-risk asthma as they have become deprived of regular clinical evaluations. However, COVID-19 also provided important lessons about implementing novel directions for care. Per
Externí odkaz:
https://doaj.org/article/0551c30f284945bab762e4c847c24cd6
Autor:
Pieter P E van Lierop, Sigrid M Swagemakers, Charlotte I de Bie, Sabine Middendorp, Peter van Baarlen, Janneke N Samsom, Wilfred F J van Ijcken, Johanna C Escher, Peter J van der Spek, Edward E S Nieuwenhuis
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e79549 (2013)
ObjectiveIn current clinical practice, optimal treatment of inflammatory bowel disease (IBD) aims at the induction and maintenance of clinical remission. Clinical remission is apparent when laboratory markers of inflammation are normal and clinical s
Externí odkaz:
https://doaj.org/article/efa5ee04a5654b7d8d2d142109cfe77b
Autor:
Lilian F. de Ruiter, Michiel Kleerebezem, Pieter P. E. van Lierop, Sahar El Aidy, Johan C. de Jongste, Beatrix E Elink-Schuurman, Michael Groeneweg, Janneke N. Samsom, Jeroen Hol, Y. Simons-Oosterhuis, Georg Kraal, Celia L Menckeberg, H Rolien C Raatgeep, Anita M. Korteland-van Male, Edward E. S. Nieuwenhuis, Dicky J. Lindenbergh-Kortleve
Publikováno v:
Gut 64 (2015)
ResearcherID
Gut, 64(6), 884-893. BMJ PUBLISHING GROUP
Gut, 64(6), 884-893. BMJ Publishing Group
Menckeberg, C, Hol, J, Simons-Oosterhuis, Y, Raatgeep, H, de Ruiter, L, Lindenbergh-Kortleve, D, Korteland-van Male, A, El Aidy, S, van Lierop, P, Kleerebezem, M, Groeneweg, M, Kraal, G, Elink-Schuurman, B, de Jongste, J, Nieuwenhuis, E & Samsom, J 2015, ' Human buccal epithelium acquires microbial hyporesponsiveness at birth, a role for secretory leukocyte protease inhibitor ', Gut, vol. 64, no. 6, pp. 884-893 . https://doi.org/10.1136/gutjnl-2013-306149
Gut, 64, 884-893
ResearcherID
Gut, 64(6), 884-893. BMJ PUBLISHING GROUP
Gut, 64(6), 884-893. BMJ Publishing Group
Menckeberg, C, Hol, J, Simons-Oosterhuis, Y, Raatgeep, H, de Ruiter, L, Lindenbergh-Kortleve, D, Korteland-van Male, A, El Aidy, S, van Lierop, P, Kleerebezem, M, Groeneweg, M, Kraal, G, Elink-Schuurman, B, de Jongste, J, Nieuwenhuis, E & Samsom, J 2015, ' Human buccal epithelium acquires microbial hyporesponsiveness at birth, a role for secretory leukocyte protease inhibitor ', Gut, vol. 64, no. 6, pp. 884-893 . https://doi.org/10.1136/gutjnl-2013-306149
Gut, 64, 884-893
Objective Repetitive interaction with microbial stimuli renders epithelial cells (ECs) hyporesponsive to microbial stimulation. Previously, we have reported that buccal ECs from a subset of paediatric patients with Crohn9s disease are not hyporespons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3021b32520773f2aad0cb29244bf4e32
https://doi.org/10.1136/gutjnl-2013-306149
https://doi.org/10.1136/gutjnl-2013-306149
Autor:
Edward E. S. Nieuwenhuis, Dicky J. Lindenbergh-Kortleve, Colin de Haar, Janneke N. Samsom, Leonie S. van Rijt, Johanna C. Escher, Bart N. Lambrecht, Pieter P. E. van Lierop, Y. Simons-Oosterhuis
Publikováno v:
Inflammatory Bowel Diseases, 16(3), 442-451. Oxford University Press
Inflammatory bowel diseases, 16(3), 442-451. John Wiley and Sons Inc.
Inflammatory bowel diseases, 16(3), 442-451. John Wiley and Sons Inc.
Background: T-cells are a main target for antiinflammatory drugs in inflammatory bowel disease. As the innate immune system is also implicated in the pathogenesis of these diseases, T-cell suppressors may not only inhibit T-cell-dependent production
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e796eabe55f7992266fb5c6bab775a85
https://doi.org/10.1002/ibd.21073
https://doi.org/10.1002/ibd.21073
Autor:
Peter J. van der Spek, Sigrid M. A. Swagemakers, Edward E. S. Nieuwenhuis, Johanna C. Escher, Sabine Middendorp, Charlotte I. de Bie, Wilfred F. J. van IJcken, Pieter P. E. van Lierop, Janneke N. Samsom, Peter van Baarlen
Publikováno v:
PLoS ONE, 8(11)
PLoS ONE
PLoS One (print), 8(11). Public Library of Science
PLoS ONE, Vol 8, Iss 11, p e79549 (2013)
PLoS ONE 8 (2013) 11
PLoS ONE
PLoS One (print), 8(11). Public Library of Science
PLoS ONE, Vol 8, Iss 11, p e79549 (2013)
PLoS ONE 8 (2013) 11
ObjectiveIn current clinical practice, optimal treatment of inflammatory bowel disease (IBD) aims at the induction and maintenance of clinical remission. Clinical remission is apparent when laboratory markers of inflammation are normal and clinical s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6947a94f7e81a2c85f15403ce5ffbb16
https://research.wur.nl/en/publications/gene-expression-analysis-of-peripheral-cells-for-subclassificatio
https://research.wur.nl/en/publications/gene-expression-analysis-of-peripheral-cells-for-subclassificatio
Publikováno v:
Journal of Pediatric Gastroenterology and Nutrition, 48, 142-151. Lippincott Williams & Wilkins
Crohn disease and ulcerative colitis are chronic inflammatory diseases of the intestinal tract commonly denoted as inflammatory bowel diseases. It has been proposed that these diseases result from aberrant mucosal immune responses to nonpathogenic mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7058d44a6ab09a09998b11a1c662a5de
https://pure.eur.nl/en/publications/da6daf8a-a50a-4df8-b93c-fe542b6e3350
https://pure.eur.nl/en/publications/da6daf8a-a50a-4df8-b93c-fe542b6e3350
Autor:
Janneke N. Samsom, Gerard M. Damen, Pieter P. E. van Lierop, Johanna C. Escher, Edward E. S. Nieuwenhuis
Publikováno v:
The Lancet. 368:578
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::643d4e8b363e5389aa09aa84c07103b9
https://doi.org/10.1016/s0140-6736(06)69193-9
https://doi.org/10.1016/s0140-6736(06)69193-9